Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
Saved in:
| Title: | Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. |
|---|---|
| Authors: | Kim JL; UBC, Department of Medicine, Vancouver, Canada., Gerrie AS; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Savage KJ; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Villa D; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Scott D; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Craig JW; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Farinha P; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Skinnider B; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Slack G; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Connors JM; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Sehn LH; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Venner C; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 346-352. Date of Electronic Publication: 2023 Dec 29. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38156444 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kim+JL%22">Kim JL</searchLink>; UBC, Department of Medicine, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Gerrie+AS%22">Gerrie AS</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Savage+KJ%22">Savage KJ</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Villa+D%22">Villa D</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Scott+D%22">Scott D</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Craig+JW%22">Craig JW</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Farinha+P%22">Farinha P</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Skinnider+B%22">Skinnider B</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Slack+G%22">Slack G</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Connors+JM%22">Connors JM</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Sehn+LH%22">Sehn LH</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Venner+C%22">Venner C</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 346-352. <i>Date of Electronic Publication: </i>2023 Dec 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38156444 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2023.2290466 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 346 Titles: – TitleFull: Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kim JL – PersonEntity: Name: NameFull: Gerrie AS – PersonEntity: Name: NameFull: Savage KJ – PersonEntity: Name: NameFull: Villa D – PersonEntity: Name: NameFull: Scott D – PersonEntity: Name: NameFull: Craig JW – PersonEntity: Name: NameFull: Farinha P – PersonEntity: Name: NameFull: Skinnider B – PersonEntity: Name: NameFull: Slack G – PersonEntity: Name: NameFull: Connors JM – PersonEntity: Name: NameFull: Sehn LH – PersonEntity: Name: NameFull: Venner C – PersonEntity: Name: NameFull: Freeman CL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2024 Mar Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1029-2403 Numbering: – Type: volume Value: 65 – Type: issue Value: 3 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |